Device Trauma

Motoband

Payments companies reported to CMS as associated with Motoband. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1.3Massociated payments (2023-2025)

3,202clinicians with associated payments

5companies reporting

By year

2023 $471K

2024 $267K

2025 $591K

Payments reported as associated with Motoband, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Foot & Ankle Surgery $456K

Orthopaedic Surgery $275K

Foot and Ankle Surgery $243K

Podiatrist $208K

Urology $32K

Orthopaedic Trauma $21K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Motoband

These are the largest totals companies reported as associated with Motoband. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Bradley Lamm	West Palm Beach, FL	Foot and Ankle Surgery	$122,455.02
Michael Campbell	Norfolk, VA	Orthopaedic Surgery	$86,013.93
Craig Breslauer	Stuart, FL	Foot & Ankle Surgery	$82,363.52
David Yeager	Morrison, IL	Podiatrist	$67,361.71
Scott Shawen	Charlotte, NC	Orthopaedic Surgery	$50,074.06
Walter Butler	Memphis, TN	Foot & Ankle Surgery	$49,029.38
Patrick Briggs	Webster, TX	Podiatrist	$43,138.74
Stuart Miller	Baltimore, MD	Foot and Ankle Surgery	$41,785.26
Terrence Philbin	Worthington, OH	Orthopaedic Surgery	$34,541.95
Norman Waldrop	Birmingham, AL	Foot and Ankle Surgery	$32,303.67

Prescribed Motoband?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.